Neuroone Medical Technologies Earnings & Revenue FAQ
What were NMTC's earnings last quarter?
On Invalid Date, Neuroone Medical Technologies (NASDAQ: NMTC) reported Q4 2022 earnings per share (EPS) of -$0.11, up 38.89% year over year. Total Neuroone Medical Technologies earnings for the quarter were -$1.73 million. In the same quarter last year, Neuroone Medical Technologies's earnings per share (EPS) was -$0.18.
As of Q1 2023, Neuroone Medical Technologies's earnings has grown year over year. Neuroone Medical Technologies's earnings in the past year totalled -$8.92 million.
What is NMTC's earnings date?
Neuroone Medical Technologies's earnings date is Invalid Date. Add NMTC to your watchlist to be reminded of NMTC's next earnings announcement.
What was NMTC's revenue last quarter?
On Invalid Date, Neuroone Medical Technologies (NASDAQ: NMTC) reported Q4 2022 revenue of $1.57 million up 3,812.48% year over year. In the same quarter last year, Neuroone Medical Technologies's revenue was $40.12 thousand.
What was NMTC's revenue growth in the past year?
As of Q1 2023, Neuroone Medical Technologies's revenue has grown 1,827.66% year over year. This is 1,820.33 percentage points higher than the US Medical Devices industry revenue growth rate of 7.33%. Neuroone Medical Technologies's revenue in the past year totalled $3.65 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.